WO2005034741A1 - Lancing device end cap with skin-engaging jaws - Google Patents

Lancing device end cap with skin-engaging jaws Download PDF

Info

Publication number
WO2005034741A1
WO2005034741A1 PCT/US2004/024393 US2004024393W WO2005034741A1 WO 2005034741 A1 WO2005034741 A1 WO 2005034741A1 US 2004024393 W US2004024393 W US 2004024393W WO 2005034741 A1 WO2005034741 A1 WO 2005034741A1
Authority
WO
WIPO (PCT)
Prior art keywords
endcap
lancing device
jaws
slot
contact face
Prior art date
Application number
PCT/US2004/024393
Other languages
French (fr)
Inventor
Stephen Flynn
Richard W. Levaughn
Christopher J. Ruf
Gwenn E. Kennedy
Michael V. Lipoma
Juan D. Salleras
Jac Holzaepfel
Sylvia Ramos
Original Assignee
Facet Technologies, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Facet Technologies, Llc filed Critical Facet Technologies, Llc
Publication of WO2005034741A1 publication Critical patent/WO2005034741A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150061Means for enhancing collection
    • A61B5/150068Means for enhancing collection by tissue compression, e.g. with specially designed surface of device contacting the skin area to be pierced
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades

Definitions

  • the present invention relates generally to medical devices and procedures, and more particularly to lancing devices for sampling blood or other bodily fluids.
  • the invention more particularly relates to an end cap for use in conjunction with a lancing device that allows for the collection of an increased volume of blood or bodily fluid to be sampled.
  • a lancet having a sharp lancing tip typically is mounted, permanently or releasably, to the drive mechanism of a lancing device.
  • the drive mechanism includes one or more springs, cams, motors, or other mechanism(s) for moving the lancing tip from a retracted position shielded within a housing of the lancing device to an extended position outside of the housing for lancing the subject's skin.
  • the lancing device may also include a cocking mechanism for arming the drive mechanism, and/or a triggering mechanism for firing the device.
  • the housing of the lancing device typically includes an endcap with an opening through which the lancing tip extends in its extended position.
  • the endcap may be releasably or permanently attached to the remainder of the housing, or can comprise an integral part of the housing.
  • the fingertips have a greater density of nerve endings than alternate sampling sites, resulting in greater pain sensation from fingertip lancing than lancing at alternate sites.
  • alternate sampling sites typically contain a lower density of capillaries or a deeper capillary bed than the fingertips, alternate sampling sites often yield insufficient
  • the present invention is an endcap for a lancing device that enables collection of an increased volume of blood or other body fluid to be sampled from a sampling site of a human or animal subject.
  • the device of the present invention is suitable for use at fingertip sampling sites, but is also well suited for use at alternate sampling sites such as the forearm and/or earlobe.
  • the invention is a sampling method for increasing collected sample size of blood or other body fluid from a sampling site.
  • the present invention is an endcap for a lancing device.
  • the endcap preferably has a first end for connection to the lancing device and a second end including an opening for passage of a sharp tip portion of a lancet.
  • the endcap preferably further includes a contact face around the opening and a slot extending through the contact face, the slot separating at least the second end of the endcap into an opposed pair of jaws.
  • the invention is a lancing device for collecting a sample of body fluid from a sampling site on the skin of a subject.
  • the lancing device preferably includes a lancet and a housing comprising an endcap, the lancet being movable between a first position within the housing and a second position wherein at least a sharp tip portion of the lancet extends through the endcap.
  • the endcap preferably has first and second opposed jaws movable between an unbiased position wherein the jaws are spaced a distance apart from one another, and a biased position wherein the jaws are squeezed toward one another.
  • the invention is a method of lancing skin to collect a fluid sample, the method preferably including the steps of placing a contact face of a lancing device against a subject's skin at a sampling site, the contact face having first and second portions separated by a slot; lancing the skin at the sampling site; and pinching the first and second portions of the contact face toward one another to compress the skin at the sampling site.
  • FIGURE 1 shows a perspective view of an endcap for a lancing device according to an example embodiment of the present invention.
  • FIGURE 2 shows a perspective view of an endcap for a lancing device according to another example embodiment of the present invention.
  • Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about,” it will be understood that the particular value forms another embodiment.
  • FIG. 1 and 2 show two example embodiments of endcaps 10 (corresponding reference numbers are indicated with primes in Fig. 2) for a lancing device, according to the present invention.
  • the endcap 10 preferably comprises a first end 12 for releasable or permanent attachment to the remainder of a housing of a lancing device. Alternatively, the endcap forms an integral part of the housing of the lancing device.
  • the endcap 10 can be adapted for use with any of a appropriate configuration of coupling or attachment features of the first end 12.
  • the second end 14 of the endcap 10 preferably defines an opening 16 through which the sharp lancet tip projects in its extended position to penetrate the skin at the intended sampling site.
  • the endcap is preferably formed of an engineering or medical-grade polymer, plastic, or other material.
  • a slot 20 preferably extends across the contact face 22 of the second end 14 of the endcap, preferably through the center of the opening 16, and through at least a portion of the length of the endcap body along opposite sidewall portions thereof.
  • the slot 20 separates the second end 14 of the endcap into opposed first and second jaws 30a, 30b.
  • the slot 20 does not extend through the entire length of the endcap 10, so that a base portion proximal the first end 12 of the endcap joins the first and second jaws 30a, 30b and allows the jaws to be pinched together at their free ends and resiliently return to their separated positions when released.
  • the width of the slot 20 in the contact face 22 is preferably at least about 1 mm, to permit passage of the sharp lancet tip and to capture an amount of tissue between the jaws sufficient to stimulate a desired amount of blood-flow toward the sampling site when pinched together.
  • the width of the slot 20 is preferably no more than about 4 to 5 mm, to prevent a standard lancet body from passing completely therethrough and being discharged from the lancing device or becoming stuck in the opening 16. More preferably, the width of the slot 20 is between about 2 mm and about 3 mm.
  • the width of the slot 20 is preferably between about 10% to about 25%, and more preferably about 15%, of the overall diameter or outside dimension of the contact face 22.
  • the contact face 22 optionally includes one or more surface features, such as a raised contact ring 40, one or more ribs or protuberances, recesses, or the like, for increasing the surface area of contact with the skin around the sampling site and/or stimulating blood-flow to the sampling site.
  • flats 50 are formed along the sides of the endcap body, on each jaw 30a, 30b opposite the slot 20, fH ⁇ lGILf S ⁇ .gi?J nc ?h .the Jaws. together. Injhe ⁇ rpbodiment of
  • the sides of the endcap body are ribbed or knurled to provide a gripping surface 60' on each jaw 30a', 30b' opposite the slot 20'.
  • the contact face 22 is placed against the skin around the sampling site, the device is triggered to lance the skin at the sampling site, and the user alternately squeezes the jaws 30a, 30b together and releases the jaws to spring back apart under the bias of the endcap material's internal resiliency. This squeezing and releasing can be repeated as necessary until the desired sample size is expressed from the sampling site wound.
  • a steady light pressure and/or a twisting, rocking and/or toggling motion is applied to the lancing device against the skin around the sampling site.

Abstract

An endcap for a lancing device, the endcap (10) comprising a contact face (22) for contact with the skin around a sampling site, and a slot (20) across the contact face (22) to form an opposed pair of jaws (30a,b) that can be pinched toward one another and will resiliently spring back apart when released, thereby alternately pinching and tensioning tissue around the sampling site to enhance sample collection and prevent premature wound closure.

Description

LANCING DEVICE END CAP WITH SKIN-ENGAGING JAWS
Cross-Reference to Related Application
[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 60/503,910, filed September 18, 2003, the entirety of which is hereby incorporated herein by reference for all purposes. Technical Field [0002] The present invention relates generally to medical devices and procedures, and more particularly to lancing devices for sampling blood or other bodily fluids. The invention more particularly relates to an end cap for use in conjunction with a lancing device that allows for the collection of an increased volume of blood or bodily fluid to be sampled.
Background of the Invention
[0003] Many medical procedures require puncturing of the skin, and sometimes underlying tissues, of a human or animal subject. For example, a sharp lancet tip is commonly used to puncture the subject's skin for sampling of blood or other body fluid, as for example in blood glucose monitoring by diabetics. Generally, lancet blades or needles
Figure imgf000003_0001
pain to the patient. A lancet having a sharp lancing tip typically is mounted, permanently or releasably, to the drive mechanism of a lancing device. The drive mechanism includes one or more springs, cams, motors, or other mechanism(s) for moving the lancing tip from a retracted position shielded within a housing of the lancing device to an extended position outside of the housing for lancing the subject's skin. The lancing device may also include a cocking mechanism for arming the drive mechanism, and/or a triggering mechanism for firing the device. The housing of the lancing device typically includes an endcap with an opening through which the lancing tip extends in its extended position. The endcap may be releasably or permanently attached to the remainder of the housing, or can comprise an integral part of the housing.
[0004] One common problem that has been found to exist with many known lancets and lancing devices is the closure of the puncture site before an adequate volume of blood has been collected. Premature closure of the puncture requires additional blood to be drawn from the patient, often in a separate and sometimes less desirable location, resulting in an increase in pain and stress to the subject. Costs also increase, as multiple lancets are required to acquire an adequate sample. This is particularly the case when alternate sampling sites other than the fingertips, such as for example the forearm or earlobe, are lanced. Lancing at such alternate sampling sites may be desirable because repeated lancing of the fingertips can result in callous formation, leading to less consistent sampling and decreased sensitivity of the fingertips. In addition, the fingertips have a greater density of nerve endings than alternate sampling sites, resulting in greater pain sensation from fingertip lancing than lancing at alternate sites. To increase patient compliance with a prescribed sampling regimen, it is desirable to minimize pain resulting from the lancing operation. However, because alternate sites typically contain a lower density of capillaries or a deeper capillary bed than the fingertips, alternate sampling sites often yield insufficient
[0005] Attempts have been made to provide lancing devices that inhibit premature closure of the puncture site and yield increased sample size. Such attempts have included the use of a stimulator member slideably mounted to the housing for cyclically pumping around the puncture site to "milk" the wound. Although utilizing the aforementioned pumping sequence may allow a larger sample to be collected before closure of the puncture site, occasionally a sample is still insufficient, and another lancing operation to collect blood or analytic fluid is required. Additionally, the repeated application and release of pressure from such pumping can result in contact between the sample and the lancing device, smearing and/or contaminating the sample and necessitating another lancing operation, and/or can lead to bruising of the tissue surrounding the sampling site. Also, the provision of a translationally mounted stimulator member results in increased complexity and cost of the lancing device.
[0006] Thus it can be seen that needs exist for improved lancing devices and methods to facilitate increased sample volume of blood or other analytic fluid, and to prevent premature closure of the sampling site. Needs further exist for such mechanisms and methods that are readily adaptable to current lancing devices and procedures, and which can be utilized for lancing at fingertip as well as alternate sample collection sites.
Summary of the Invention
[0007] In example forms, the present invention is an endcap for a lancing device that enables collection of an increased volume of blood or other body fluid to be sampled from a sampling site of a human or animal subject. The device of the present invention is suitable for use at fingertip sampling sites, but is also well suited for use at alternate sampling sites such as the forearm and/or earlobe. In further embodiments, the invention is a sampling method for increasing collected sample size of blood or other body fluid from a sampling site.
[0008] In one aspect, the present invention is an endcap for a lancing device. The endcap preferably has a first end for connection to the lancing device and a second end including an opening for passage of a sharp tip portion of a lancet. The endcap preferably further includes a contact face around the opening and a slot extending through the contact face, the slot separating at least the second end of the endcap into an opposed pair of jaws.
[0009] In another aspect, the invention is a lancing device for collecting a sample of body fluid from a sampling site on the skin of a subject. The lancing device preferably includes a lancet and a housing comprising an endcap, the lancet being movable between a first position within the housing and a second position wherein at least a sharp tip portion of the lancet extends through the endcap. The endcap preferably has first and second opposed jaws movable between an unbiased position wherein the jaws are spaced a distance apart from one another, and a biased position wherein the jaws are squeezed toward one another.
[00010] In still another. aspect, the invention is a method of lancing skin to collect a fluid sample, the method preferably including the steps of placing a contact face of a lancing device against a subject's skin at a sampling site, the contact face having first and second portions separated by a slot; lancing the skin at the sampling site; and pinching the first and second portions of the contact face toward one another to compress the skin at the sampling site.
[00011] These and other aspects, features and advantages of the invention will be understood with reference to the drawing figures and detailed description herein, and will be realized by means of the various elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following brief description of the drawings and detailed description of the invention are exemplary and explanatory of preferred embodiments of the invention, and are not restrictive of the invention, as claimed.
Brief Description of the Drawings
[00012] FIGURE 1 shows a perspective view of an endcap for a lancing device according to an example embodiment of the present invention.
[00013] FIGURE 2 shows a perspective view of an endcap for a lancing device according to another example embodiment of the present invention.
Detailed Description of Example Embodiments
[00014] The present invention may be understood more readily by reference to the following detailed description of the invention taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Also, as used in the specification including the appended claims, the singular forms "a," "an," and "the" include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from "about" or "approximately" one particular value and/or to "about" or "approximately" another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about," it will be understood that the particular value forms another embodiment.
[00015] With reference now to the drawing figures, Figures 1 and 2 show two example embodiments of endcaps 10 (corresponding reference numbers are indicated with primes in Fig. 2) for a lancing device, according to the present invention. The endcap 10 preferably comprises a first end 12 for releasable or permanent attachment to the remainder of a housing of a lancing device. Alternatively, the endcap forms an integral part of the housing of the lancing device. The endcap 10 can be adapted for use with any of a
Figure imgf000007_0001
appropriate configuration of coupling or attachment features of the first end 12. The second end 14 of the endcap 10 preferably defines an opening 16 through which the sharp lancet tip projects in its extended position to penetrate the skin at the intended sampling site. The endcap is preferably formed of an engineering or medical-grade polymer, plastic, or other material.
[00016] A slot 20 preferably extends across the contact face 22 of the second end 14 of the endcap, preferably through the center of the opening 16, and through at least a portion of the length of the endcap body along opposite sidewall portions thereof. The slot 20 separates the second end 14 of the endcap into opposed first and second jaws 30a, 30b. Preferably, the slot 20 does not extend through the entire length of the endcap 10, so that a base portion proximal the first end 12 of the endcap joins the first and second jaws 30a, 30b and allows the jaws to be pinched together at their free ends and resiliently return to their separated positions when released. The width of the slot 20 in the contact face 22 is preferably at least about 1 mm, to permit passage of the sharp lancet tip and to capture an amount of tissue between the jaws sufficient to stimulate a desired amount of blood-flow toward the sampling site when pinched together. The width of the slot 20 is preferably no more than about 4 to 5 mm, to prevent a standard lancet body from passing completely therethrough and being discharged from the lancing device or becoming stuck in the opening 16. More preferably, the width of the slot 20 is between about 2 mm and about 3 mm. The width of the slot 20 is preferably between about 10% to about 25%, and more preferably about 15%, of the overall diameter or outside dimension of the contact face 22.
[00017] The contact face 22 optionally includes one or more surface features, such as a raised contact ring 40, one or more ribs or protuberances, recesses, or the like, for increasing the surface area of contact with the skin around the sampling site and/or stimulating blood-flow to the sampling site. In the embodiment of Fig. 1 , flats 50 are formed along the sides of the endcap body, on each jaw 30a, 30b opposite the slot 20, fHΘlGILf Sώ^^ .gi?Jnc?h .the Jaws. together. Injhe^rpbodiment of
Fig. 2, the sides of the endcap body are ribbed or knurled to provide a gripping surface 60' on each jaw 30a', 30b' opposite the slot 20'.
[00018] In a preferred method of operation according to the present invention, the contact face 22 is placed against the skin around the sampling site, the device is triggered to lance the skin at the sampling site, and the user alternately squeezes the jaws 30a, 30b together and releases the jaws to spring back apart under the bias of the endcap material's internal resiliency. This squeezing and releasing can be repeated as necessary until the desired sample size is expressed from the sampling site wound. Optionally, a steady light pressure and/or a twisting, rocking and/or toggling motion is applied to the lancing device against the skin around the sampling site. Pinching the jaws 30a, 30b together and releasing them to spring back apart, with the contact face 22 pressed against the skin around the sampling site, causes the skin at the sampling site to be alternately compressed and tensioned. Compressing and tensioning the skin in this manner prior to and/or during lancing may assist in directing subcutaneous blood to pool in the area of the sampling site. Compressing and tensioning the skin in this manner after lancing may further assist in expressing blood out of the wound at the sampling site, as well as prevent premature wound closure.
[00019] While the invention has been described with reference to preferred and example embodiments, it will be understood by those skilled in the art that a variety of modifications, additions and deletions are within the scope of the invention, as defined by the following claims.

Claims

What is claimed is: 1. An endcap for a lancing device, the endcap having a first end for connection to the lancing device and a second end comprising an opening for passage of a sharp tip portion of a lancet, the endcap further comprising a contact face around the opening and a slot extending through the contact face, the slot separating at least the second end of the endcap into an opposed pair of jaws.
2. The endcap of Claim 1 , at least partially formed of a resilient material such that the opposed pair of jaws can be pinched toward one another and will resiliently spring back apart when released.
3. The endcap of Claim 1 , further comprising a raised contact ring projecting from the contact face.
4. The endcap of Claim 1 , wherein each of said opposed pair of jaws comprises a gripping surface on the sides of the endcap opposite the slot.
5. The endcap of Claim 1 , wherein the slot between the opposed pair of jaws has a width of between 1 mm and 5 mm.
6. The endcap of Claim 5, wherein the slot between the opposed pair of jaws has a - i tfrf^ et ert^ ©ut^-m 'tσ^a ou^3"mm.
7. The endcap of Claim 1 , wherein the slot between the opposed pair of jaws has a width of between about 10% to about 25% of an outside dimension of the contact face.
8. The endcap of Claim 1 , wherein the slot between the opposed pair of jaws has a width of about 15% of an outside dimension of the contact face.
9. A lancing device for collecting a sample of body fluid from a sampling site on the skin of a subject, said lancing device comprising a lancet and a housing comprising an endcap, the lancet being movable between a first position within the housing and a second position wherein at least a sharp tip portion of the lancet extends through the endcap, wherein the endcap comprises first and second opposed jaws movable between an unbiased position wherein said jaws are spaced a distance apart from one another, and a biased position wherein said jaws are squeezed toward one another.
10. The lancing device of Claim 9, wherein the endcap comprises a contact face defining an opening through which the sharp tip portion of the lancet extends when the lancet is in its second position.
11. The lancing device of Claim 10, wherein the endcap further comprises a slot extending across the contact face.
12. The lancing device of Claim 11 , wherein the slot separates at least one end of the endcap into an opposed pair of jaws.
13. The lancing device of Claim 12, wherein the endcap further comprises a gripping surface on an outside portion of each of the opposed pair of jaws.
14. The lancing device of Claim 11 , wherein the slot has a width of between 1 mm and 5 mm.
15. The lancing device of Claim 14, wherein the slot has a width of between about 2 mm to about 3 mm.
16. The lancing device of Claim 11 , wherein the slot has a width of between about 10% to about 25% of an outside dimension of the contact face.
17. The lancing device of Claim 10, further comprising a raised contact ring projecting from the contact face.
18. The lancing device of Claim 9, wherein the endcap is at least partially formed of a resilient material to allow the endcap to flex back and forth between its unbiased and biased positions.
19. A method of lancing skin to collect a fluid sample, the method comprising: placing a contact face of a lancing device against a subject's skin at a sampling site, the contact face comprising first and second portions separated by a slot; lancing the skin at the sampling site; and pinching the first and second portions of the contact face toward one another to compress the skin at the sampling site.
20. The method of Claim 19, further comprising releasing the first and second portions of the contact face to move apart from one another to tension the skin at the sampling site.
PCT/US2004/024393 2003-09-18 2004-07-28 Lancing device end cap with skin-engaging jaws WO2005034741A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50391003P 2003-09-18 2003-09-18
US60/503,910 2003-09-18

Publications (1)

Publication Number Publication Date
WO2005034741A1 true WO2005034741A1 (en) 2005-04-21

Family

ID=34434868

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/024393 WO2005034741A1 (en) 2003-09-18 2004-07-28 Lancing device end cap with skin-engaging jaws

Country Status (1)

Country Link
WO (1) WO2005034741A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4620549A (en) * 1985-01-25 1986-11-04 Becton, Dickinson And Company Blood collection assembly
US6045567A (en) * 1999-02-23 2000-04-04 Lifescan Inc. Lancing device causing reduced pain
US6283982B1 (en) * 1999-10-19 2001-09-04 Facet Technologies, Inc. Lancing device and method of sample collection
US6451040B1 (en) * 2000-09-01 2002-09-17 Bayer Corporation Adjustable endcap for lancing device
US6464649B1 (en) * 1997-11-21 2002-10-15 Amira Medical Body fluid sampling device
US20020151920A1 (en) * 1999-12-08 2002-10-17 Jeremy Marshall Integration of a lancette with its capturing and removing cap
US6752817B2 (en) * 2001-03-26 2004-06-22 Bayer Corporation Split pressure ring for lancing device and method of operation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4620549A (en) * 1985-01-25 1986-11-04 Becton, Dickinson And Company Blood collection assembly
US6464649B1 (en) * 1997-11-21 2002-10-15 Amira Medical Body fluid sampling device
US6045567A (en) * 1999-02-23 2000-04-04 Lifescan Inc. Lancing device causing reduced pain
US6283982B1 (en) * 1999-10-19 2001-09-04 Facet Technologies, Inc. Lancing device and method of sample collection
US20020151920A1 (en) * 1999-12-08 2002-10-17 Jeremy Marshall Integration of a lancette with its capturing and removing cap
US6451040B1 (en) * 2000-09-01 2002-09-17 Bayer Corporation Adjustable endcap for lancing device
US6752817B2 (en) * 2001-03-26 2004-06-22 Bayer Corporation Split pressure ring for lancing device and method of operation

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9802007B2 (en) 2001-06-12 2017-10-31 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US9186468B2 (en) 2002-04-19 2015-11-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9498160B2 (en) 2002-04-19 2016-11-22 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation

Similar Documents

Publication Publication Date Title
WO2005034741A1 (en) Lancing device end cap with skin-engaging jaws
US20070032813A1 (en) Lancing device with pivoting end cap
US20090105612A1 (en) Lancing device end cap with pressure-actuated surface features
JP4732652B2 (en) Specimen cutting device
US20080058848A1 (en) Endcap for a Sampling Device
US20060287664A1 (en) Endcap for a fluid sampling device
WO2005034778A1 (en) Lancing device end cap with flexing contact elements
WO2005034721A2 (en) Lancing device end cap with blood-directing contact face
WO2005035018A2 (en) Lancing device end cap with rocking-actuated surface features
EP1245187B1 (en) Split pressure ring for lancing device and blood drawing system
JP3802568B2 (en) Body fluid sampling device
KR100641620B1 (en) Apparatus for stimulating the efflux of a body fluid from a body part, and compression device
RU2269954C2 (en) Cap for lancet device for punching dermal tissue (versions), cap for lancet device for punching tip of finger, cap for lancet device for punching curvilinear dermal tissue and lancet device for punching dermal tissue
US20100106058A1 (en) Blood and interstitial fluid sampling device
US20060184189A1 (en) Cap for a dermal tissue lancing device
JPWO2004021886A1 (en) Invasive device and biological fluid measuring device
JP2003102712A (en) Device for squeezing body fluid from incision part
CA2461370A1 (en) Method and apparatus for sampling bodily fluid
AU2001266766A1 (en) Cap for a lancing device
HU219921B (en) Device for making blood test, especially from fingers
MX2007002863A (en) Damping system for a lancet using compressed air.
US20080195131A1 (en) Lancing Device End Cap With Rocking-Actuated Surface Features
WO2005096942A1 (en) Endcap for a vacuum lancing fixture

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase